[Correspondence] Fasting conditions in clinical oncology trials and drug labelling

The timing of drug administration in relation to meals could have a major effect on bioavailability and plasma concentrations of oral oncology drugs. The Comment by Floor J E Lubberman and colleagues1 provides a timely discussion on the effect of different types of fasting regimens in oncology trials on drug exposure and anticancer treatment. However, some information and arguments should be clarified.

http://ift.tt/2gx8wsh